Mesenchymal stem cells from sternum : the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics

Detalhes bibliográficos
Autor(a) principal: Dias, Lucinara Dadda
Data de Publicação: 2017
Outros Autores: Casali, Karina Rabello, Ghem, Carine, Silva, Melissa Kristocheck da, Sausen, Grasiele, Palma, Patricia Vianna Bonini, Covas, Dimas T., Kalil, Renato Abdala Karam, Schaan, Beatriz D'Agord, Nardi, Nance Beyer, Markoski, Melissa Medeiros
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/170614
Resumo: Background: In an attempt to increase the therapeutic potential for myocardial regeneration, there is a quest for new cell sources and types for cell therapy protocols. The pathophysiology of heart diseases may affect cellular characteristics and therapeutic results. Methods: To study the proliferative and differentiation potential of mesenchymal stem cells (MSC), isolated from bone marrow (BM) of sternum, we made a comparative analysis between samples of patients with ischemic (IHD) or non-ischemic valvular (VHD) heart diseases. We included patients with IHD (n = 42) or VHD (n = 20), with average age of 60 years and no differences in cardiovascular risk factors. BM samples were collected (16.4 ± 6 mL) and submitted to centrifugation with Ficoll-Paque, yielding 4.5 ± 1.5 × 107 cells/mL. Results: Morphology, immunophenotype and differentiation ability had proven that the cultivated sternal BM cells had MSC features. The colony forming unit-fibroblast (CFU-F) frequency was similar between groups (p = 0.510), but VHD samples showed positive correlation to plated cells vs. CFU-F number (r = 0.499, p = 0.049). The MSC culture was established in 29% of collected samples, achieved passage 9, without significant difference in expansion kinetics between groups (p > 0.05). Dyslipidemia and the use of statins was associated with culture establishment for IHD patients (p = 0.049 and p = 0.006, respectively). Conclusions: Together, these results show that the sternum bone can be used as a source for MSC isolation, and that ischemic or valvular diseases do not influence the cellular yield, culture establishment or in vitro growth kinetics.
id UFRGS-2_19e26f05037cd81b458da3a6daa86900
oai_identifier_str oai:www.lume.ufrgs.br:10183/170614
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Dias, Lucinara DaddaCasali, Karina RabelloGhem, CarineSilva, Melissa Kristocheck daSausen, GrasielePalma, Patricia Vianna BoniniCovas, Dimas T.Kalil, Renato Abdala KaramSchaan, Beatriz D'AgordNardi, Nance BeyerMarkoski, Melissa Medeiros2017-11-28T02:29:17Z20171479-5876http://hdl.handle.net/10183/170614001053379Background: In an attempt to increase the therapeutic potential for myocardial regeneration, there is a quest for new cell sources and types for cell therapy protocols. The pathophysiology of heart diseases may affect cellular characteristics and therapeutic results. Methods: To study the proliferative and differentiation potential of mesenchymal stem cells (MSC), isolated from bone marrow (BM) of sternum, we made a comparative analysis between samples of patients with ischemic (IHD) or non-ischemic valvular (VHD) heart diseases. We included patients with IHD (n = 42) or VHD (n = 20), with average age of 60 years and no differences in cardiovascular risk factors. BM samples were collected (16.4 ± 6 mL) and submitted to centrifugation with Ficoll-Paque, yielding 4.5 ± 1.5 × 107 cells/mL. Results: Morphology, immunophenotype and differentiation ability had proven that the cultivated sternal BM cells had MSC features. The colony forming unit-fibroblast (CFU-F) frequency was similar between groups (p = 0.510), but VHD samples showed positive correlation to plated cells vs. CFU-F number (r = 0.499, p = 0.049). The MSC culture was established in 29% of collected samples, achieved passage 9, without significant difference in expansion kinetics between groups (p > 0.05). Dyslipidemia and the use of statins was associated with culture establishment for IHD patients (p = 0.049 and p = 0.006, respectively). Conclusions: Together, these results show that the sternum bone can be used as a source for MSC isolation, and that ischemic or valvular diseases do not influence the cellular yield, culture establishment or in vitro growth kinetics.application/pdfengJournal of translational medicine. London. Vol. 15 (May 2017), 161, 11 p.Doenças cardiovascularesDiabetes mellitusMortalidadeMSC establishmentStem cells cultureCell therapyValvular heart diseaseIschemic heart diseaseMesenchymal stem cells from sternum : the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kineticsEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSORIGINAL001053379.pdf001053379.pdfTexto completo (inglês)application/pdf1709723http://www.lume.ufrgs.br/bitstream/10183/170614/1/001053379.pdf62ae4804ebd8c9b8772ad056e183820eMD51TEXT001053379.pdf.txt001053379.pdf.txtExtracted Texttext/plain42911http://www.lume.ufrgs.br/bitstream/10183/170614/2/001053379.pdf.txtd18aad0ade1df4b0f82e2b99e0529736MD5210183/1706142022-09-24 05:00:13.166578oai:www.lume.ufrgs.br:10183/170614Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2022-09-24T08:00:13Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv Mesenchymal stem cells from sternum : the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics
title Mesenchymal stem cells from sternum : the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics
spellingShingle Mesenchymal stem cells from sternum : the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics
Dias, Lucinara Dadda
Doenças cardiovasculares
Diabetes mellitus
Mortalidade
MSC establishment
Stem cells culture
Cell therapy
Valvular heart disease
Ischemic heart disease
title_short Mesenchymal stem cells from sternum : the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics
title_full Mesenchymal stem cells from sternum : the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics
title_fullStr Mesenchymal stem cells from sternum : the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics
title_full_unstemmed Mesenchymal stem cells from sternum : the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics
title_sort Mesenchymal stem cells from sternum : the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics
author Dias, Lucinara Dadda
author_facet Dias, Lucinara Dadda
Casali, Karina Rabello
Ghem, Carine
Silva, Melissa Kristocheck da
Sausen, Grasiele
Palma, Patricia Vianna Bonini
Covas, Dimas T.
Kalil, Renato Abdala Karam
Schaan, Beatriz D'Agord
Nardi, Nance Beyer
Markoski, Melissa Medeiros
author_role author
author2 Casali, Karina Rabello
Ghem, Carine
Silva, Melissa Kristocheck da
Sausen, Grasiele
Palma, Patricia Vianna Bonini
Covas, Dimas T.
Kalil, Renato Abdala Karam
Schaan, Beatriz D'Agord
Nardi, Nance Beyer
Markoski, Melissa Medeiros
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Dias, Lucinara Dadda
Casali, Karina Rabello
Ghem, Carine
Silva, Melissa Kristocheck da
Sausen, Grasiele
Palma, Patricia Vianna Bonini
Covas, Dimas T.
Kalil, Renato Abdala Karam
Schaan, Beatriz D'Agord
Nardi, Nance Beyer
Markoski, Melissa Medeiros
dc.subject.por.fl_str_mv Doenças cardiovasculares
Diabetes mellitus
Mortalidade
topic Doenças cardiovasculares
Diabetes mellitus
Mortalidade
MSC establishment
Stem cells culture
Cell therapy
Valvular heart disease
Ischemic heart disease
dc.subject.eng.fl_str_mv MSC establishment
Stem cells culture
Cell therapy
Valvular heart disease
Ischemic heart disease
description Background: In an attempt to increase the therapeutic potential for myocardial regeneration, there is a quest for new cell sources and types for cell therapy protocols. The pathophysiology of heart diseases may affect cellular characteristics and therapeutic results. Methods: To study the proliferative and differentiation potential of mesenchymal stem cells (MSC), isolated from bone marrow (BM) of sternum, we made a comparative analysis between samples of patients with ischemic (IHD) or non-ischemic valvular (VHD) heart diseases. We included patients with IHD (n = 42) or VHD (n = 20), with average age of 60 years and no differences in cardiovascular risk factors. BM samples were collected (16.4 ± 6 mL) and submitted to centrifugation with Ficoll-Paque, yielding 4.5 ± 1.5 × 107 cells/mL. Results: Morphology, immunophenotype and differentiation ability had proven that the cultivated sternal BM cells had MSC features. The colony forming unit-fibroblast (CFU-F) frequency was similar between groups (p = 0.510), but VHD samples showed positive correlation to plated cells vs. CFU-F number (r = 0.499, p = 0.049). The MSC culture was established in 29% of collected samples, achieved passage 9, without significant difference in expansion kinetics between groups (p > 0.05). Dyslipidemia and the use of statins was associated with culture establishment for IHD patients (p = 0.049 and p = 0.006, respectively). Conclusions: Together, these results show that the sternum bone can be used as a source for MSC isolation, and that ischemic or valvular diseases do not influence the cellular yield, culture establishment or in vitro growth kinetics.
publishDate 2017
dc.date.accessioned.fl_str_mv 2017-11-28T02:29:17Z
dc.date.issued.fl_str_mv 2017
dc.type.driver.fl_str_mv Estrangeiro
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/170614
dc.identifier.issn.pt_BR.fl_str_mv 1479-5876
dc.identifier.nrb.pt_BR.fl_str_mv 001053379
identifier_str_mv 1479-5876
001053379
url http://hdl.handle.net/10183/170614
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Journal of translational medicine. London. Vol. 15 (May 2017), 161, 11 p.
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/170614/1/001053379.pdf
http://www.lume.ufrgs.br/bitstream/10183/170614/2/001053379.pdf.txt
bitstream.checksum.fl_str_mv 62ae4804ebd8c9b8772ad056e183820e
d18aad0ade1df4b0f82e2b99e0529736
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv
_version_ 1801224932921704448